Sort by
Refine Your Search
-
Operations Research and Operations Management, such as network theory, combinatorial optimization, and econometrics. The project pursues three interrelated aims: first, to characterize how network structure
-
or resist specific policies. The project combines theory development with qualitative fieldwork in the Belgian and French contexts. The project requires a PhD candidate who combines theoretical curiosity with
-
specific focus on the role of women) in the Congolese diaspora in Flanders. Ultimately, the project will deliver a novel transnational epistemological and analytical framework and empirically grounded theory
-
technologies as promising mechanisms to reduce the burden on data managers currently involved in this process. You obtained your master’s degree (or you are about to graduate in 2026) in Computer Science, or a
-
.); To have some experience in computational programming; To have demonstrated verbal and written communication skills in English; To have a collaborative mindset: To enjoy working with others to achieve common
-
research. The program ultimately leads to a doctoral degree and prepares the student for an academic career at a top university or a career as a researcher in a policy institution. Detailed information about
-
, signal processing (or a similar degree with an equivalent academic level). - You have an interest in designing EEG-BCI experiments (expected for about 20% of the PHD) - You have a solid mathematically
-
reasoning about tree ensembles. This work will be undertaken in the context of Flanders AI Research Program (https://www.flandersairesearch.be/en ) 3) 1-2 PhD students working with Prof. Jesse Davis
-
* for combinatorial solving; some details can be found below. The field of combinatorial optimization is concerned with developing generic tools that take a declarative problem description and automatically compute
-
for ~75% of cases) lead to progressive bilateral cyst formation in renal tubular epithelium, resulting in end-stage kidney disease by age 60 in approximately 50% of patients. Currently, there is no cure